Abstract:Background Hepatocellular carcinoma (HCC) ranks as the sixth most prevalent cancer and the third leading cause of tumor-related death, so it is urgently needed to discover efficient markers and targets for therapy. β-1,3- N -acetylgalactosaminyltransferase II (B3GALNT2) belongs to the β-1,3-glycosyltransferases (b3GT) family and has been reported to regulate development of both normal and tumor tissues. However, studies on the functions of B3GALNT2 in cancer are quite limited. Here we investigated the potential role of B3GALNT2 in HCC progression. Methods Western blot, qPCR, and immunohistochemistry assays were performed to quantify the relative expression of B3GALNT2 in HCC. The functions of B3GALNT2 in tumor progression were evaluated in HCC cell lines and nude mice. Metabolomics analysis was applied to detect alternatively expressed small molecules. Enzyme activity assays were employed to determine the tautomerase activity of macrophage inhibitory factor (MIF). Results For expression analysis, higher levels of B3GALNT2 were observed in tumor tissues compared with adjacent normal tissues, and upregulation of B3GALNT2 correlated with increased tumor size and worse overall survival. Changing levels of B3GALNT2 did not influence cell viability in vitro but promoted tumor growth via enhancing macrophage recruitment in vivo. Furthermore, acetoacetate was identified as a key molecule in B3GALNT2-mediated macrophage recruitment. Mechanistically, B3GALNT2 downregulated expression of enzymes involved in acetoacetate-related metabolism, and reduction of acetoacetate revived MIF activity, thus promoting macrophage recruitment. Conclusions This study evaluated B3GALNT2 as a tumor marker in HCC and revealed functions of B3GALNT2 in metabolic transformation and microenvironmental remodeling in HCC. Mechanistically, B3GALNT2 reduced expression of some metabolic enzymes and thus downregulated levels of secreted acetoacetate. This relieved the activity of MIF and enhanced macrophage recruitment to promote tumor growth.

N‐glycosylation by N‐acetylglucosaminyltransferase V Enhances the Interaction of CD147/basigin with Integrin Β1 and Promotes HCC Metastasis

<i>N</i>-glycosylation by <i>N</i>-acetylglucosaminyltransferase IVa enhances the interaction of integrin 1 with vimentin and promotes hepatocellular carcinoma cell motility

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

c-Jun-dependent β3GnT8 promotes tumorigenesis and metastasis of hepatocellular carcinoma by inducing CD147 glycosylation and altering N -glycan patterns.

N -acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147

Β3gnt8 Promotes Gastric Cancer Invasion by Regulating the Glycosylation of CD147

Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation.

Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro.

N-linked Glycosylation at Asn152 on CD147 Affects Protein Folding and Stability: Promoting Tumour Metastasis in Hepatocellular Carcinoma

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

β3GnT8 regulates the metastatic potential of colorectal carcinoma cells by altering the glycosylation of CD147.

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Β3gnt8 Plays an Important Role in CD147 Signal Transduction As an Upstream Modulator of MMP Production in Tumor Cells

N-acetylglucosaminyltransferase V Activity in Metastatic Models of Human Hepatocellular Carcinoma in Nude Mice.

Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

Β3gnt8 Promotes Colorectal Cancer Cells Invasion Via CD147/MMP2/Galectin3 Axis

GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis

Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells.

Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation

The Role of N-acetylglucosaminyltransferases V in the Malignancy of Human Hepatocellular Carcinoma

Increased B3GALNT2 in Hepatocellular Carcinoma Promotes Macrophage Recruitment Via Reducing Acetoacetate Secretion and Elevating MIF Activity